Tag: Daniel C. Malone

ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL CONSIDERS THE USE OF REAL-WORLD EVIDENCE IN HEALTH CARE DECISION MAKING

Washington, DC—May 23, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 5—Use of Real-Word Evidence in Payer Decision Making: Fact or Fiction?—was held this morning in Washington, DC, USA.

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , ,

ISPOR EXPANDS LEADERSHIP TEAM WITH CHIEF SCIENCE OFFICER

RICHARD J. WILLKE, PHD JOINS ASSOCIATION IN KEY LEADERSHIP ROLE  Princeton, NJ—April 18, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it is expanding its leadership team with the appointment of Richard J. Willke, PhD as

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR “ON THE ROAD” IN 1ST QUARTER 2016

ANNOUNCEMENT  ISPOR “ON THE ROAD” IN 1ST QUARTER 2016  Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) attended a number of industry meetings during the first quarter of 2016. The following is a sampling of ISPOR’s

Posted in Announcements Tagged with: , , , , , ,